MicroRNAs in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy requiring improved early diagnosis and prognostic assessment. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, have emerged as promising biomarkers for ESCC. We conducted a comprehensive literature search in PubMed for studies published up to 2025. While miRNA profiles in ESCC tissues show significant associations with lymphatic dissemination, tumor progression, and patient survival, clinical translation remains limited by issues of sensitivity, specificity, and standardization. This review summarizes current knowledge on miRNA expression in ESCC, focusing on lymphatic dissemination and prognostic implications. We also explore circulating miRNAs as minimally invasive tools for early detection and treatment monitoring. By integrating recent findings, this article provides a critical overview of miRNA-based biomarkers to improve early diagnostic accuracy and therapeutic decision-making in ESCC.

Authors

Institutions

Publication Details

Journal
Epigenomics
Published
2026-02-01
DOI
https://doi.org/10.1080/17501911.2026.2624361
Citations
1
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
24.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MicroRNAs in esophageal squamous cell carcinoma

Qiwei Liu, Ziqin Liu, Ming Wang, Yi-Jun Qi
1 citations
Epigenomics
MicroRNA in disease regulation
24.82
article

MicroRNAs in esophageal squamous cell carcinoma

Qiwei Liu, Ziqin Liu, Ming Wang, Yi-Jun Qi
article en
1 citations

Abstract

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy requiring improved early diagnosis and prognostic assessment. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, have emerged as promising biomarkers for ESCC. We conducted a comprehensive literature search in PubMed for studies published up to 2025. While miRNA profiles in ESCC tissues show significant associations with lymphatic dissemination, tumor progression, and patient survival, clinical translation remains limited by issues of sensitivity, specificity, and standardization. This review summarizes current knowledge on miRNA expression in ESCC, focusing on lymphatic dissemination and prognostic implications. We also explore circulating miRNAs as minimally invasive tools for early detection and treatment monitoring. By integrating recent findings, this article provides a critical overview of miRNA-based biomarkers to improve early diagnostic accuracy and therapeutic decision-making in ESCC.

EpigenomicsVol. 18(2)
Henan Cancer Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Xuchang University (CN)
Peace, Justice and strong institutions
Openalex Percentile: Top 1%
MicroRNA in disease regulation
24.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MicroRNAs in esophageal squamous cell carcinoma — Qiwei Liu, Ziqin Liu, et al. · Epigenomics (2026) | TGRS Research Map | TGRS